000 | 01025 a2200277 4500 | ||
---|---|---|---|
005 | 20250516070349.0 | ||
264 | 0 | _c20120413 | |
008 | 201204s 0 0 eng d | ||
022 | _a1555-905X | ||
024 | 7 |
_a10.2215/CJN.10711011 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLarsson, Tobias E | |
245 | 0 | 0 |
_aFGF23 beyond mineral metabolism: a bridge to cardiovascular disease. _h[electronic resource] |
260 |
_bClinical journal of the American Society of Nephrology : CJASN _cDec 2011 |
||
300 |
_a2735-7 p. _bdigital |
||
500 | _aPublication Type: Editorial; Comment | ||
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFibroblast Growth Factor-23 |
650 | 0 | 4 |
_aFibroblast Growth Factors _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney Failure, Chronic _xtherapy |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPeritoneal Dialysis |
773 | 0 |
_tClinical journal of the American Society of Nephrology : CJASN _gvol. 6 _gno. 12 _gp. 2735-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.2215/CJN.10711011 _zAvailable from publisher's website |
999 |
_c21380825 _d21380825 |